Table 1.
Strain or plasmid | Descriptiona | Reference or source |
---|---|---|
Strains | ||
E. coli | ||
S17-1λpir | E. coli strain for plasmid mobilization | 44 |
DH5α | E. coli strain for cloning purposes | 25 |
C. crescentus | ||
NA1000 | Synchronizable derivative of wild-type CB15 | 15 |
MM60 | NA1000 strain with pRM6 translational fusion integrated in the genome | This study |
MM61 | NA1000 strain with pRM7 translational fusion integrated in the genome | This study |
MM63 | NA1000 strain with pRM8 translational fusion integrated in the genome | This study |
MM62 | NA1000 strain with pRM9 translational fusion integrated in the genome | This study |
MM64 | NA1000 strain with pRM10 translational fusion integrated in the genome | This study |
MM8 | NA1000 ΔcspA | 31 |
MM30 | NA1000 ΔcspB | This study |
MM26 | NA1000 ΔcspC | 4 |
MM9 | NA1000 ΔcspD | 31 |
MM28 | NA1000 ΔcspA ΔcspB | This study |
Plasmids | ||
pGEM-T Easy | Cloning vector; Ampr | Promega |
pNPTS138 | Suicide vector containing oriT and sacB; Kanr | D. Alley |
pRKlacZ290 | Vector for translational fusion with lacZ gene; Tetr | 21 |
pMR20 | Broad-host-range, low-copy-number vector; Tetr | 41 |
pJBZ281 | pRK2-derived vector with promoterless lacZ gene; Kanr | M. R. K. Alley |
pEL4 | Fragment containing cspD promoter cloned into pRKlacZ290 | 31 |
pEL6 | Fragment containing cspC promoter cloned into pRKlacZ290 | 31 |
pRM1 | Fragment from −380 to +162 of cspA amplified using CSPA-B/CSPA-R4 transcriptionally fused to lacZ into pRKlacZ290 | This study |
pRM2 | Fragment from −196 to +162 of cspA amplified using CSPA-R5/CSPA-R4 transcriptionally fused to lacZ into pRKlacZ290 | This study |
pRM3 | Fragment from −380 to −133 upstream from cspA amplified using CSPA-B/CSPA-R8 transcriptionally fused to lacZ into pRKlacZ290 | This study |
pRM4 | Fragment from −734 to +152 of cspB amplified using CSPB-F/CSPB-R4 transcriptionally fused to lacZ into pRKlacZ290 | This study |
pRM5 | Fragment from −187 to +27 of cspB amplified using CSPB-R1/CSPB-C transcriptionally fused to lacZ into pRKlacZ290 | This study |
pRM6 | Fragment from −380 to +162 of cspA amplified using CSPA-B/CSPA-R4 translationally fused in frame to lacZ into pJBZ281 | This study |
pRM7 | Fragment from −380 to +3 of cspA amplified using CSPA-B/CSPA-R2 translationally fused in frame to lacZ into pJBZ281 | This study |
pRM8 | Fragment from −734 to +152 of cspB amplified using CSPB-F/CSPB-R4 translationally fused in frame to lacZ into pJBZ281 | This study |
pRM9 | Fragment from −734 to −93 fused to the fragment −17 to +3 of cspB amplified using CSPB-F/CSPB-R3 translationally fused in frame to lacZ into pJBZ281 | This study |
pRM10 | Fragment from −356 to +3 of cspB amplified using CSPB-A/CSPB-R2 translationally fused in frame to lacZ into pJBZ281 | This study |
pRM11 | Fragment amplified with CSPA-A/CSPA-B containing cspA gene cloned into pMR20 | This study |
pRM12 | Fragment amplified with CSPB-A/CSPB-B containing cspB gene cloned into pRM11 | This study |
pRM13 | Fragment from −380 to −90 fused to the fragment −15 to +3 of cspA amplified using CSPA-B/CSPA-R3 translationally fused in frame to lacZ into pJBZ281 | This study |
Fragment positions are relative to the ATG.